ATE273702T1 - Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon - Google Patents

Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon

Info

Publication number
ATE273702T1
ATE273702T1 AT96917578T AT96917578T ATE273702T1 AT E273702 T1 ATE273702 T1 AT E273702T1 AT 96917578 T AT96917578 T AT 96917578T AT 96917578 T AT96917578 T AT 96917578T AT E273702 T1 ATE273702 T1 AT E273702T1
Authority
AT
Austria
Prior art keywords
compositions
production processes
iron compounds
complexes
iron
Prior art date
Application number
AT96917578T
Other languages
English (en)
Inventor
Michael Arthur Stockham
Robert Charles Hider
Original Assignee
Vitra Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9511818.8A external-priority patent/GB9511818D0/en
Priority claimed from GBGB9517537.8A external-priority patent/GB9517537D0/en
Application filed by Vitra Pharmaceuticals Ltd filed Critical Vitra Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE273702T1 publication Critical patent/ATE273702T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Soft Magnetic Materials (AREA)
  • Hard Magnetic Materials (AREA)
AT96917578T 1995-06-10 1996-06-10 Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon ATE273702T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9511818.8A GB9511818D0 (en) 1995-06-10 1995-06-10 Iron compounds compositions and uses thereof
GBGB9517537.8A GB9517537D0 (en) 1995-08-26 1995-08-26 Iron compounds, compositions and uses thereof
PCT/GB1996/001382 WO1996041627A2 (en) 1995-06-10 1996-06-10 Iron compounds, compositions, methods of making the same and uses thereof

Publications (1)

Publication Number Publication Date
ATE273702T1 true ATE273702T1 (de) 2004-09-15

Family

ID=26307198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917578T ATE273702T1 (de) 1995-06-10 1996-06-10 Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon

Country Status (7)

Country Link
US (2) US6339080B1 (de)
EP (1) EP0833627B1 (de)
AT (1) ATE273702T1 (de)
AU (1) AU6010696A (de)
DE (1) DE69633178T2 (de)
ES (1) ES2230564T3 (de)
WO (1) WO1996041627A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273702T1 (de) 1995-06-10 2004-09-15 Vitra Pharmaceuticals Ltd Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
EP1318804B1 (de) * 2000-09-19 2004-11-17 Vitra Pharmaceuticals Ltd. Eisenverbindungen
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US20070270591A1 (en) * 2006-05-16 2007-11-22 Ashmead H Dewayne Iron (II) amino acid chelates with reducing agents attached thereto
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
CN103865390A (zh) * 2012-12-18 2014-06-18 锜玮科技(深圳)有限公司 疏水镀膜液及其所制备的抗污抗指纹镀膜层的生产工艺
WO2015101971A1 (en) 2014-01-06 2015-07-09 Iron Therapeutics Holdings Ag Dosage regimen of ferric trimaltol
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
EP3157516A4 (de) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmazeutische zusammensetzungen mit eisencitrat und verfahren zur herstellung davon
GB201418710D0 (en) * 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
WO2022056378A1 (en) * 2020-09-11 2022-03-17 Renibus Therapeutics, Inc. Method for treating cancer with kidney protection
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR1500765A (fr) * 1963-09-19 1967-11-10 Pfizer & Co C Dérivés de l'acide pyroméconique et procédé pour leur préparation
SE322866B (de) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
EP0094149B1 (de) 1982-03-24 1986-09-10 National Research Development Corporation Pharmazeutische Zusammensetzungen, die Eisen-Komplexe von N-substituierten 3-Hydroxypyrid-2-on- oder -4-on-Derivaten enthalten
GR78491B (de) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (de) 1982-10-22 1987-07-29 National Research Development Corporation Pharmazeutische Zusammensetzungen
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ATE273702T1 (de) 1995-06-10 2004-09-15 Vitra Pharmaceuticals Ltd Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
WO1996041627A2 (en) 1996-12-27
AU6010696A (en) 1997-01-09
DE69633178D1 (de) 2004-09-23
US20030069218A1 (en) 2003-04-10
DE69633178T2 (de) 2005-08-11
WO1996041627A3 (en) 1997-03-13
US6339080B1 (en) 2002-01-15
EP0833627A2 (de) 1998-04-08
US6635631B2 (en) 2003-10-21
EP0833627B1 (de) 2004-08-18
ES2230564T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
ATE273702T1 (de) Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
DE69332469D1 (de) Metallkomplexe von wasserlöslichen texaphyrinen
EP0732930A4 (de) Zusammensetzungen, die die Apoptose inhibitieren, Methode zur Reinigung der Zusammensetzunge und ihre Verwendung
AU2001252958A1 (en) Compounds and methods to treat alzheimer's disease
NZ335981A (en) Ketobenzamides as calpain inhibitors
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
AU2001271686A1 (en) Compounds to treat alzheimer's disease
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
CA2077812A1 (en) Web dressing and method for its production
BR9913890B1 (pt) composição de cuidado oral e uso de um complexo de cobre ligado a maltol, hinoquitiol ou etilmatol.
CA2268321A1 (en) Use of metal complexes to treat gastrointestinal infections
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
BG93995A (bg) Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им и използването им за получаване на противоязвени средства
CY1954A (en) 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents
DE60107272D1 (de) Eisenverbindungen
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
IL159993A0 (en) Platinum complexes and their use in cancer treatment
DE69524093D1 (de) Kombination von prokoagulans und cytokin oder induktor seiner produktion für die behandlung von tumoren
SE9601396D0 (sv) New therapeutic treatment 2
CA2144728A1 (en) Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
BG102667A (en) Diosgenine-containing composition
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties